Literature DB >> 18457069

Surveillance of births conceived with various infertility therapies in Massachusetts, January-March 2005.

Emily Lu1, Wanda D Barfield, Nancy Wilber, Hafsatou Diop, Susan E Manning, Sally Fogerty.   

Abstract

OBJECTIVE: Nationally, infertility therapies (IFTs) are increasingly used to overcome fecundity issues. However, it is unclear to what extent noninvasive IFTs are used compared with assisted reproductive technology. To better understand outcomes related to the increasing use of all types of IFTs, we compared self-reported IFT use from a Massachusetts pilot Pregnancy Risk Assessment Monitoring System (MA-PRAMS) to IFT use recorded on birth certificates (BCs).
METHODS: In 2005, Massachusetts conducted a three-month pilot study modeled after the Centers for Disease Control and Prevention's PRAMS, a population-based surveillance system that monitors pregnancy experiences. Descriptive and bivariate analyses compared responses to MA-PRAMS survey questions regarding IFT use with data collected on BCs from the same women sampled.
RESULTS: According to MA-PRAMS, 6.1% of live births were conceived using IFTs compared with 3.1% reported on BCs. Reported IFT use varied by maternal age and plurality. For women aged 18-34 years, IFT use reported on MA-PRAMS (5.0%) was 2.5 times higher than that reported on BCs (2.0%). For women aged 35 years or older, reported IFT use was comparable in both systems. For women giving birth to singletons, IFT use reported on MA-PRAMS (5.5%) was three times higher than that reported on BCs (1.8%).
CONCLUSIONS: Higher use of IFTs was reported by MA-PRAMS than on BCs, particularly among younger women and those having singleton births. These findings suggest that self-reported IFT use might be a more sensitive method for states to use in assessing population-based IFT usage among women and monitoring trends in adverse birth outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18457069      PMCID: PMC2239326          DOI: 10.1177/003335490812300209

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  7 in total

1.  Validity of self-reported use of assisted reproductive technology treatment among women participating in the Pregnancy Risk Assessment Monitoring System in five states, 2000.

Authors:  Laura A Schieve; Deborah Rosenberg; Arden Handler; Kristin Rankin; Meredith A Reynolds
Journal:  Matern Child Health J       Date:  2006-05-24

Review 2.  What is the population-based risk of preterm birth among twins and other multiples?

Authors:  J L Kiely
Journal:  Clin Obstet Gynecol       Date:  1998-03       Impact factor: 2.190

Review 3.  Multiple gestation pregnancy. The ESHRE Capri Workshop Group.

Authors: 
Journal:  Hum Reprod       Date:  2000-08       Impact factor: 6.918

4.  Contribution of assisted reproductive technology and ovulation-inducing drugs to triplet and higher-order multiple births--United States, 1980-1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-06-23       Impact factor: 17.586

5.  Cerebral palsy and multiple births.

Authors:  P O Pharoah; T Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-11       Impact factor: 5.747

6.  Trends in twin and triplet births: 1980-97.

Authors:  J A Martin; M M Park
Journal:  Natl Vital Stat Rep       Date:  1999-09-14

7.  Trends in multiple births conceived using assisted reproductive technology, United States, 1997-2000.

Authors:  Meredith A Reynolds; Laura A Schieve; Joyce A Martin; Gary Jeng; Maurizio Macaluso
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

  7 in total
  2 in total

1.  Rising preterm birth rates, 1989-2004: changing demographics or changing obstetric practice?

Authors:  Tyler J VanderWeele; John D Lantos; Diane S Lauderdale
Journal:  Soc Sci Med       Date:  2011-12-06       Impact factor: 4.634

2.  Infertility treatment in a population-based sample: 2004-2005.

Authors:  Sara E Simonsen; Laurie Baksh; Joseph B Stanford
Journal:  Matern Child Health J       Date:  2012-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.